But the key take away from the 9-to-5 vote against lorcaserin from a panel of experts convened by the Food and Drug Administration is that the bar for obesity drugs is very high.

FORBES: Don't Buy Orexigen After Arena's Failure

No administration figures showed up at Lugar's hearing, a fact that drew a rebuke from the panel's top Democrat, Sen.

CNN: Bush Iraq policy faces tough questions?on Capitol Hill